eRegister's captcha

Patent Register Details

Print page icon Print this page

PATENT REGISTER
A Supplementary Protection Certificate (SPC) exists for this Patent. To view the SPC Details click following SPC number(s): 2018/010
Status Granted Patent No. 1827461
Application No. 05823474.1 Date of Filing 20/12/2005
Date Grant Published 29/02/2012 Application Published 05/09/2007
Title of Invention CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSIS
Priority
Priority Country Filing Date Application No.
 European Patent Office (EPO)  22/12/2004  04106909
 United States of America  22/12/2004  638669 P
Inventors DE LUCA, Giampiero
YTHIER, Arnaud
MUNAFO, Alain
LOPEZ-BRESNAHAN, Maria
Current Proprietor Merck Serono SA
Centre Industriel
1267 Coinsins, Vaud
SWITZERLAND
Address for service FRKelly
Waterways House
Grand Canal Quay
Dublin D02 PD39
IRELAND
Renewal Fees
Year Date Renewed
 20  01/10/2024
 19  09/10/2023
 18  11/10/2022
 17  09/11/2021
 16  09/12/2020
 15  09/12/2019
 14  10/12/2018
 13  11/12/2017
 12  09/12/2016
 11  09/12/2015
 10  09/12/2014
 9  10/12/2013
 8  18/12/2012
Publication Language English
Translation Received Date
05/03/2012 Divisional Application number: 10182632.9 Publication number: 2275110 Date of receipt: 29/09/2010
05/03/2012 Divisional Application number: 10182676.6 Publication number: 2263678 Date of receipt: 29/09/2010
06/03/2012 Address for Service recorded as FRKelly, 27 Clyde Road, Ballsbridge, Dublin 4, Ireland received on 01/03/2012.
14/02/2018 Request for grant a Supplementary Protection Certificate, citing Patent number 1827461 as the relevant basic patent, in respect of the product Cladribine filed on 09/02/2018. Reference number of request is 2018/010.
08/09/2025 Request for grant of Supplementary Protection Certification No. 2018/010 rejected in respect of Article 10(2) of Regulation (EC) No. 469/2009